Navigation Links
Crisis Exemption Granted to Market Avipel(R) Corn Seed Treatment in Louisiana
Date:2/27/2009

NEW CASTLE, Del., Feb. 27 /PRNewswire/ -- Arkion(R) Life Sciences has received a Section 18 Crisis Exemption to market Avipel(R) Corn Seed Treatment in Louisiana effective March 1, 2009. The EPA approval means that Louisiana farmers can use Avipel(R) to protect field and sweet corn from marauding blackbirds and grackles for the 2009 planting season. Formerly known as Avitec, Avipel(R) is applied to corn seed before planting and effectively stops birds from damaging crops by eating the newly planted seeds.

This is the first year Avipel(R) has received approval in Louisiana. The product is non-lethal to birds and has been shown to be highly effective in protecting corn seed from birds in over four years of use in states with particular bird problems such as Mississippi, Michigan, Minnesota, South Dakota and Wisconsin. Information about approved uses and labels may be found at the Arkion(R) Life Sciences web site: www.ArkionLS.com.

According to Ken Ballinger (VP, Airepel(R)), Arkion(R) Life Sciences has been a pioneer in the development and commercialization of several formulations of bird repellent and bird management technologies. Arkion's patented formulations of anthraquinone have been effectively repelling geese with FlightControl(R) Plus and repelling birds from structures through the Airepel(R) Humane Bird Management business.

Arkion(R) Life Sciences LLC, based in New Castle, Delaware, is a technology-based company leading in the discovery, development and marketing of environmentally friendly, natural or nature identical bioactive compounds. The company has over 500 patents and patent applications worldwide around these technologies, including the area of feed preservation with N-Sure(R), and employs biotechnology to capitalize on new opportunities in the nutraceutical, pharmaceutical, animal health and agricultural markets. Arkion(R) has three major businesses: Airepel(R), supplying bird repellents which feature a non-lethal method to control where birds feed and roost; Hyperimmune eggs with markets in human and animal nutrition; and Bio-Technical Resources (Manitowoc, WI) which develops processes and products based upon fermentation technology such as glucosamine, N-acetylglucosamine and natamycin.


'/>"/>
SOURCE Arkion Life Sciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Crisis Management PR Firms Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny
2. Countering an approaching water crisis
3. In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance
4. Life Science Labs Reacting to the Economic Crisis
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Pharmions Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
7. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
8. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
9. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
10. Odyssey Thera Granted U.S. Patent for Animal Imaging
11. Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... 17, 2017  On January 10 at the Medtech ... Morgan Healthcare Conference in San Francisco ... , spoke to pharmaceutical leaders and public and private ... break down and destroy biofilms.  Biofilms ... antibiotics and the body,s immune system from eradicating chronic ...
(Date:1/16/2017)... , Jan. 16, 2017   Valentin A. ... Tracey, MD , president and CEO of The ... completed an analysis of how the nervous system regulates ... and develop bioelectronic medicine devices to treat ... Nature Neuroscience . The paper examines ...
(Date:1/16/2017)...  Eurofins Genomics today announced the expansion of its ... receive their primers in a shorter turnaround time, without ... with other providers. Express oligos are available for anyone ... no additional fee. Researchers use the oligos ... sequencing, genotyping, site-directed mutagenesis, and cloning. Often, they are ...
(Date:1/14/2017)... , Jan. 13, 2017  The Alliance for Safe ... response to FDA final guidance on biologic ... continued leadership in emphasizing the importance of distinct naming ... aware of the benefits biosimilars will bring to patients, ... Yet the portion of the Guidance dealing with ...
Breaking Biology Technology:
(Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... e-Government, Public Safety, HealthCare, and Finance sectors announced today that Leaders ... to implement and deploy a community-based supportive services program to reduce ... , further expanding its presence in the state. ... This new program, which is expected ...
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/15/2016)... Dec. 15, 2016   WaferGen Bio-systems, Inc. ... technology company, announced today that on December 13, 2016, ... of The Nasdaq Stock Market LLC which acknowledged that, ... of WaferGen,s common stock had been at $1.00 or ... regained compliance with Listing Rule 5550(a)(2) of the Nasdaq ...
Breaking Biology News(10 mins):